Skip to main content

Smith, Moore & Co.

SEC CIK
0000200724
Latest filing
Aug 12, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Smith, Moore & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
28,543
Value
$7.18M
% of portfolio
0.5%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Smith, Moore & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202628,543$7.18M0.5%−718−2.5%ReducedHolders
Q1 202629,261$6.36M0.5%+1,659+6.0%AddedHolders
Q4 202527,602$6.31M0.5%−1,502−5.2%ReducedHolders
Q3 202529,104$6.74M0.5%+431+1.5%AddedHolders
Q2 202528,673$5.32M0.4%−951−3.2%ReducedHolders
Q1 202529,624$6.21M0.6%−627−2.1%ReducedHolders
Q4 202430,251$5.38M0.5%+88+0.3%AddedHolders
Q3 202430,163$5.96M0.6%−1,837−5.7%ReducedHolders
Q2 202432,000$5.49M0.6%−1,385−4.1%ReducedHolders
Q1 202433,385$6.08M0.6%−1,734−4.9%ReducedHolders
Q4 202335,119$5.44M0.6%−757−2.1%ReducedHolders
Q3 202335,876$5.35M0.7%+450+1.3%AddedHolders
Q2 202335,426$4.77M0.6%−604−1.7%ReducedHolders
Q1 202336,030$5.74M0.8%−1,884−5.0%ReducedHolders
Q4 202237,914$6.13M0.9%−514−1.3%ReducedHolders
Q3 202238,428$5.16M0.8%−1,243−3.1%ReducedHolders
Q2 202239,671$6.08M0.9%−829−2.0%ReducedHolders
Q1 202240,500$6.57M0.9%−889−2.1%ReducedHolders
Q4 202141,389$5.60M0.8%+892+2.2%AddedHolders
Q3 202140,497$4.37M0.7%+282+0.7%AddedHolders
Q2 202140,215$4.53M0.7%+2,109+5.5%AddedHolders
Q1 202138,106$4.12M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.